<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02189369</url>
  </required_header>
  <id_info>
    <org_study_id>1311-FIVI-135-CS</org_study_id>
    <nct_id>NCT02189369</nct_id>
  </id_info>
  <brief_title>Diagnostic Test for Endometrial Receptivity 24 Hours Before Embryo Transfer</brief_title>
  <official_title>Clinical Validation of a Diagnostic Test Which Measures the Endometrial Prostaglandins Liquid 24 Hours Before Embryo Transfer and That is Capable of Predicting a State of Endometrial Receptivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Igenomix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Igenomix</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical validation study is being carried out to validate the efficacy of a test
      measuring the clinical application of prostaglandins present in the endometrial fluid in
      patients, 24 hours before the embryonic transfer. This test is capable of predicting
      endometrial receptivity without the need of performing a biopsy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>endometrial receptivity</measure>
    <time_frame>24 hours before embryo transfer</time_frame>
    <description>The endometrial samples will be extracted 24 hours before the embryo transfer in order to analyze the quantity of prostaglandins.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>15 days</time_frame>
    <description>We will reffer a correlation between the prostaglandin results and the implantation rate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>15 days</time_frame>
    <description>We will reffer a correlation between the prostaglandin results and the implantation rate.</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Day 3 embryo-Own-above cutoff</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 3 embryo transfer for IVF with own oocytes, and prostaglandine levels with higher receptivty rates</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Day 5 embryo-Own-above cutoff</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 5 embryo transfer for IVF with own oocytes, and prostaglandine levels with higher receptivty rates</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Day 3 embryo-Donor-above cutoff</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 3 embryo transfer for IVF with donor oocytes, and prostaglandine levels with higher receptivty rates</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Day 5 embryo-Donor- above cutoff</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 5 embryo transfer for IVF with donor oocytes, and prostaglandine levels with higher receptivty rates</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Day 3 embryo-Donor-lower cutoff</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 3 embryo transfer for IVF with donor oocytes, and prostaglandine levels with lower receptivty rates</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Day 5 embryo-Donor-lower cutoff</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 5 embryo transfer for IVF with donor oocytes, and prostaglandine levels with lower receptivty rates</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Day 3 embryo-own-lower cutoff</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 3 embryo transfer for IVF with own oocytes, and prostaglandine levels with lower receptivty rates</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Day 5 embryo-own-lower cutoff</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 5 embryo transfer for IVF with own oocytes, and prostaglandine levels with lower receptivty rates</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Day 3 embryo transfer</intervention_name>
    <description>Extraction of endometrial fluid, analysis of prostaglandine and Day 3 embryo transfer</description>
    <arm_group_label>Day 3 embryo-Own-above cutoff</arm_group_label>
    <arm_group_label>Day 3 embryo-Donor-above cutoff</arm_group_label>
    <arm_group_label>Day 3 embryo-Donor-lower cutoff</arm_group_label>
    <arm_group_label>Day 3 embryo-own-lower cutoff</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Day 5 embryo transfer</intervention_name>
    <description>Extraction of endometrial fluid, analysis of prostaglandine and Day 5 embryo transfer</description>
    <arm_group_label>Day 5 embryo-Own-above cutoff</arm_group_label>
    <arm_group_label>Day 5 embryo-Donor- above cutoff</arm_group_label>
    <arm_group_label>Day 5 embryo-Donor-lower cutoff</arm_group_label>
    <arm_group_label>Day 5 embryo-own-lower cutoff</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any IVF patient being treated for single or double embryo transfer

          -  BMI: 20 - 30

          -  Normal ovarian response (7 - 8 ovocitos) in IVF treatment with AFC ≥ 8, (AFC = Antral
             Follicle Count)

          -  Elective embryo transfer

          -  Normal uterine cavity

          -  Age: ≤ 38 years old for patients with own oocytes; ≤ 50 years old for patients with
             donated oocytes.

        Exclusion Criteria:

          -  Patients with recurrent miscarriages ( ≥ 2 biochemical miscarriages; ≥ 2 clinical
             miscarriage)

          -  Patients with severe male factor ( ≥ 2*106 espermatozoides/ml).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Simon, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundación IVI</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carlos Gómez, MA</last_name>
    <phone>+34670506469</phone>
    <email>carlos.gomez@igenomix.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fundación IVI</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Gómez, Ma</last_name>
      <phone>+34670506469</phone>
      <email>carlos.gomez@igenomix.com</email>
    </contact>
    <investigator>
      <last_name>Carlos Simón, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Felip Vilella, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IVI Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Gómez, MA</last_name>
      <email>carlos.gomez@igenomix.com</email>
    </contact>
    <investigator>
      <last_name>Carlos Simón, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marcos Meseguer, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sergio Cabanillas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2014</study_first_submitted>
  <study_first_submitted_qc>July 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2014</study_first_posted>
  <last_update_submitted>March 6, 2017</last_update_submitted>
  <last_update_submitted_qc>March 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Igenomix</investigator_affiliation>
    <investigator_full_name>Carlos Simon</investigator_full_name>
    <investigator_title>Dr. Carlos Simón</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

